Home > Quotes > CNCE

Concert Pharmaceuticals, Inc. Common Stock Quote & Summary Data

Get CNCE Alerts
*Delayed - data as of Apr. 28, 2016  -  Find a broker to begin trading CNCE now
Exchange: NASDAQ
Industry: Health Care
Community Rating:
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
Basic Chart Interactive Chart
Company Headlines Press Releases Market Stream
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save Stocks

Concert Pharmaceuticals, Inc. Common Stock Intraday Chart

Shares Traded

Trading Range

Intraday Last 52 Weeks
High $ 14.68 $ 25.04
Low $ 13.8383 $ 12.1579

The current last sale of $14.31 is 17.70% Higher thanthe 52 week low.

P/E Ratio

Company Description (as filed with the SEC)

We are a clinical stage biopharmaceutical company applying our extensive knowledge of deuterium chemistry to discover and develop novel small molecule drugs. Incorporation of deuterium into known molecules has the potential to provide better pharmacokinetic or metabolic properties, thereby enhancing their clinical safety, tolerability or efficacy. Our approach starts with approved drugs, advanced clinical candidates or previously studied compounds that may be improved with deuterium substitution. Our technology provides the opportunity to develop products that may compete with the non-deuterated drug in existing markets or to leverage the known activity of approved drugs to expand into new indications. Our DCE Platform® has broad potential across numerous therapeutic areas. The following table summarizes our diverse clinical pipeline of product candidates. All of these candidates are small molecules designed for oral administration.  ... More ...  

Risk Grade

Where does CNCE fit in the risk graph?

Risk Grade Scale

Nasdaq Official Price

Consensus Recommendation

Research Brokers before you trade

Want to trade FX?